Literature DB >> 3819785

Chronic progressive neurological involvement in Borrelia burgdorferi infection.

B Weder, P Wiedersheim, L Matter, A Steck, F Otto.   

Abstract

Five patients with chronic meningitis were hospitalized several times for progressive neurological symptoms. The clinical manifestations included cranial neuritis, radiculoneuritis, myelitis and encephalitis. In two cases cerebral infarction occurred. The course was commonly characterized by a tendency to deteriorate. From the clinical point of view, it was repeatedly difficult to exclude multiple sclerosis or tuberculous meningitis. Finally, specific antibodies against Borrelia burgdorferi were detected by indirect immunofluorescence assay. The diagnosis of a borreliosis was not considered initially because there was no history of tick-bite or erythema chronicum migrans, and the neurological involvement of the central nervous system seemed unusual. The latency between the first symptoms and diagnosis varied from 3 months to 5 years. After a parenteral, high-dose therapy with penicillin, there was a significant improvement in all patients. In two cases, there was evidence of intrathecally produced antibodies to myelin basic protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3819785     DOI: 10.1007/bf00314008

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  22 in total

Review 1.  Lyme disease.

Authors:  J Meyerhoff
Journal:  Am J Med       Date:  1983-10       Impact factor: 4.965

2.  Ticks, spirochetes, and new diagnostic tests for Lyme disease.

Authors:  L E Mertz; G H Wobig; J Duffy; J A Katzmann
Journal:  Mayo Clin Proc       Date:  1985-06       Impact factor: 7.616

3.  Antibiotic therapy in Lyme disease.

Authors:  A C Steere; S E Malawista; J H Newman; P N Spieler; N H Bartenhagen
Journal:  Ann Intern Med       Date:  1980-07       Impact factor: 25.391

4.  Chronic meningitis caused by a penicillin-sensitive microorganism?

Authors:  B Sköldenberg; G Stiernstedt; A Gårde; G Kolmodin; A Carlström; C E Nord
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

5.  The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.

Authors:  A R Pachner; A C Steere
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

6.  Bannwarth's syndrome (lymphocytic meningoradiculitis) in Sweden.

Authors:  B Ryberg
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

7.  Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth).

Authors:  R Ackermann; P Hörstrup; R Schmidt
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

8.  Variable major proteins of Borrellia hermsii.

Authors:  A G Barbour; S L Tessier; H G Stoenner
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

9.  Neurological findings of Lyme disease.

Authors:  A R Pachner; A C Steere
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug

10.  The clinical spectrum and treatment of Lyme disease.

Authors:  A C Steere; S E Malawista; N H Bartenhagen; P N Spieler; J H Newman; D W Rahn; G J Hutchinson; J Green; D R Snydman; E Taylor
Journal:  Yale J Biol Med       Date:  1984 Jul-Aug
View more
  21 in total

1.  Cerebral atrophy in Lyme disease.

Authors:  J Aasly; G Nilsen
Journal:  Neuroradiology       Date:  1990       Impact factor: 2.804

2.  Chronic borrelia encephalomyeloradiculitis with severe mental disturbance: immunosuppressive versus antibiotic therapy.

Authors:  H H Kollikowski; G Schwendemann; M Schulz; H Wilhelm; H J Lehmann
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

Review 3.  Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease.

Authors:  Daniel J Cameron; Lorraine B Johnson; Elizabeth L Maloney
Journal:  Expert Rev Anti Infect Ther       Date:  2014-07-30       Impact factor: 5.091

4.  Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G.

Authors:  W Kohlhepp; P Oschmann; H G Mertens
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

5.  Persistent intrathecal secretion of oligoclonal, Borrelia burgdorferi-specific IgG in chronic meningoradiculomyelitis.

Authors:  R Martin; U Martens; V Sticht-Groh; R Dörries; H Krüger
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

6.  Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients.

Authors:  R Kaiser
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

Review 7.  Neurological manifestations of Lyme borreliosis.

Authors:  W Kristoferitsch
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

8.  Prognostic B-cell epitopes on the flagellar protein of Borrelia burgdorferi.

Authors:  T Schneider; R Lange; W Rönspeck; W Weigelt; H W Kölmel
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

9.  Meningitis due to Borrelia burgdorferi in the initial stage of Lyme disease.

Authors:  H I Huppertz; V Sticht-Groh
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

10.  [Pain syndromes in tick-borne neuroborreliosis. Clinical aspects and differential diagnosis.].

Authors:  J Kohler; U Thoden
Journal:  Schmerz       Date:  1987-09       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.